TuesdayNov 14, 2023 2:57 pm

QualityStocksNewsBreaks – SOHM Inc. (SHMN) Unveils New Suite of SOHM Nutrients’ Brand Chewables

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has announced a new suite of products in the vitamin gummies space. Provided by the SOHM OTC Self-Care business unit, the new line includes 13 new SOHM Nutrients’ Brand Chewables. The new suite of chewable products offers an array of key benefits, including bone and skin health, an immune boost, mineral replenishment and sleep aid. The pocket-friendly products come in four flavors — mango, strawberry, pineapple and toffee — and are single serving, individually wrapped. The vegan chewables contain key ingredients,…

Continue Reading

TuesdayNov 14, 2023 2:44 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q1 Fiscal 2024 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today released financial results for the first quarter of the fiscal year 2024, which ended Sept. 30, 2023. “We are pleased with the continued advancements across our pharmaceutical programs and commercial operations. We are particularly excited with the recent candidate selection and official launch of our INM-901 preclinical program targeting the treatment of Alzheimer’s disease, representing a unique and innovative treatment approach compared to current options available to patients. Our commercial subsidiary, BayMedica, continues to make steady progress as a…

Continue Reading

TuesdayNov 14, 2023 1:28 pm

QualityStocksNewsBreaks — Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Releases Status Update to Ruby Graphite Project Initial Drill Program

Reflex Advanced Materials (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2), a mineral exploration company, announced the completion of its 2023 phase one drill program at its Montana-based Ruby Graphite Project. Highlights of the drill program include a total of 24 diamond drill holes being completed, totaling 3391 meters for the inaugural HQ-size drill program on the property with average drilling depth of only 141 meters because of the presence of graphitic carbon mineralization, and first-pass drilling tested an extended conductivity anomaly along an east-northeast striking marble, with plans to follow up on the areas that return the best Cg grades. In…

Continue Reading

TuesdayNov 14, 2023 1:00 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces Strong Q3 2023 Results Including 550% YoY EBITDA Growth and 5-Year-Record Net Profit

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and cybersecurity sectors, today announced financial and operating results for the three and nine months ended Sept. 30, 2023. “We are excited to announce exceptional operational performance for Q3 2023, which is reflected in our financial results. A 5-year record net profit, remarkable 550% growth in EBITDA and 74% growth in gross profit margins are clear indicators of the successful execution of our growth strategy. The significant increase in the company’s profit margins is driven by the forward momentum we’ve maintained across our projects, where margins…

Continue Reading

TuesdayNov 14, 2023 12:43 pm

QualityStocksNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) CEO Featured in Recent Podcast Release

Sekur Private Data (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is in the spotlight during a recent episode of “Swiss Made Cybersecurity,” released by CyberCrime Magazine and available on SoundCloud. During the interview, Sekur Private Data founder and CEO Alain Ghiai and CyberCrime Magazine host Paul John Spaulding discuss a variety of topics, including election security and phishing emails. The Cybercrime Magazine Podcast provides cybersecurity facts, figures, predictions and statistics as well as insightful interviews with top industry experts, Fortune 500 CISOs, and cybersecurity CEOs; the podcast also offers rundowns of the latest…

Continue Reading

TuesdayNov 14, 2023 12:32 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Applauds New Legislation Aimed to Expand U.S. Quantum Initiative

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services as well as the world’s first commercial supplier of quantum computers, has announced support for new Congressional legislation. According to the announcement, the company applauds National Quantum Initiative (“NQI”) legislation that includes all quantum computing systems and focuses on near-term application development. In addition, D-Wave CEO Dr. Alan Baratz met with members of Congress earlier this year, urging their support to reauthorize the NQI and ensure that the legislation is expanded to encompass all quantum-computing technologies, including annealing, gate model and quantum-hybrid. The new legislation is designed…

Continue Reading

TuesdayNov 14, 2023 12:23 pm

QualityStocksNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Featured in Bell2Bell Podcast

Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Longeveron’s CEO Wa’el Hashad joined the program to introduce the company and its business model. “Longeveron is a cell therapy-based biotech company. It was established in 2014 as a spin-off from a technology that was developed at the University of Miami School of Medicine by a renowned scientist and cardiologist, Dr. Josh Hare,” Hashad said. “Josh has been…

Continue Reading

TuesdayNov 14, 2023 9:30 am

PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates

PaxMedica is developing PAX-101, which utilizes the company’s proprietary source of suramin sodium, for the treatment of ASD (Autism Spectrum Disorder) There is no FDA-approved treatment for the core symptoms of autism, even though the rates of autism spectrum disorder have jumped significantly from 2000 to 2020 ASD is characterized by deficits in social communication, restricted and repetitive patterns of behavior, and significant impairment in functioning, three core aspects of the disease that PaxMedica aims to address The company announced positive topline results from a Phase 2 study evaluating PAX-101 as a potential treatment for ASD and hopes to replicate…

Continue Reading

TuesdayNov 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for potential diabetes and weight loss treatment The company hopes to make these drugs more effective with reduced side effects, and even more accessible to people living with diabetes The move is aimed to help the company partner with the behemoths in an industry projected to bring in between $150 billion and $200 billion a year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is evaluating the impact of its patented DehydraTECH(TM) technology…

Continue Reading

MondayNov 13, 2023 3:21 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Releases Q3 2023 Financial Results

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is reporting its numbers for the third quarter of 2023. Highlights of the report included revenue of $2.6 million for the quarter, an increase of 50% sequentially from Q2 and an increase of 51% on a year over year basis. Commercial revenue increased by 62% year over year and constituted 70% of total revenue over the last four quarters, up from 50% over the prior four quarters. Q3 bookings totaled $2.9 million, up 53% on a year-to-year basis with Q3 representing the company’s sixth consecutive quarter of year…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered